Solriamfetol and m-chlorophenylpiperazine cause false positive amphetamine results on urine drug screening
- 4 December 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 48 (2) , 126-129
Abstract
Urine drug screening by immunoassay is a common method to quickly identify drug exposures in the emergency setting and to detect unexpected drug exposures in a variety of patient care and occupational health settings. Although they provide rapid results, immunoassays are susceptible to cross-reactivity with other medications and metabolites. Herein we evaluate the performance of the Thermo Scientific DRI Amphetamines immunoassay for reactivity with trazodone, aripiprazole, atomoxetine, solriamfetol and relevant metabolites. Each of these compounds were spiked into drug-free urine across a range of concentrations and assessed for positivity on amphetamine screen. We demonstrate that the Thermo Scientific DRI assay is susceptible to interferences from m-chlorophenylpiperazine (mCPP), the main metabolite of trazodone, and solriamfetol. Characterization of assay-specific interferences in toxicology screening is instrumental for accurate interpretation of toxicology results, evaluation of patients in emergent settings and supporting patient care.Keywords
This publication has 17 references indexed in Scilit:
- Case Reports of Aripiprazole Causing False-Positive Urine Amphetamine Drug Screens in ChildrenPediatrics, 2015
- False-Positive Interferences of Common Urine Drug Screen Immunoassays: A ReviewJournal of Analytical Toxicology, 2014
- Amphetamine Positive Urine Toxicology Screen Secondary to AtomoxetineCase Reports in Psychiatry, 2013
- Prescription Compliance or Illicit Designer Drug Abuse?Clinical Chemistry, 2012
- The trazodone metabolite meta-chlorophenylpiperazine can cause false-positive urine amphetamine immunoassay results.Journal of Analytical Toxicology, 2011
- Frequency of False Positive Amphetamine Screens due to Bupropion Using the Syva Emit II ImmunoassayJournal of Medical Toxicology, 2010
- Detection of Novel Reactive Metabolites of Trazodone: Evidence for CYP2D6-Mediated Bioactivation of m-ChlorophenylpiperazineDrug Metabolism and Disposition, 2008
- Metabolic activation of the nontricyclic antidepressant trazodone to electrophilic quinone-imine and epoxide intermediates in human liver microsomes and recombinant P4503A4Chemico-Biological Interactions, 2005
- Effects of Genetic Polymorphism of CYP1A2 Inducibility on the Steady‐State Plasma Concentrations of Trazodone and its Active Metabolite m‐Chlorophenylpiperazine in Depressed Japanese PatientsBasic & Clinical Pharmacology & Toxicology, 2001
- Effects of Trazodone and Fluoxetine in the Treatment of Major DepressionJournal of Clinical Psychopharmacology, 1997